(NU/1433-16) NunaBio: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
What the buyer wrote
NunaBio Ltd has developed an enhanced DNA sensing platform technology and associated IP that will find application in many market sectors that require increased confidence in the sensitive detection of target DNA sequences. Consumers of diagnostic devices require their device to be sensitive and accurate. While 100% accuracy is possible, existing approaches require highly trained staff, expensive labs and significant lead time to results. These drawbacks are key drivers for the development of point-of-use devices which aim to support better decision making, reduce cost (social and economic) and time to action. The utility of such devices and therefore consumer confidence in the results they …
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- (NU/1433-16) NunaBio: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
- How they are buying
- Advertised, shortlist firstSuppliers applied to be considered, and the buyer picked who went on to bid.
- Type
- services
- Dynamic market
- Yes: you can apply to join at any time. How these work
- Where
- in the North East
- Kind of work
- Professional services
Who the buyer named
Mr Dave Anderson was the named contact on this notice.